Organization (Academic)
UNIVERSITA' DEGLI STUDI DI GENOVA
ClinicalTrials.gov lists UNIVERSITA' DEGLI STUDI DI GENOVA as lead sponsor of 21 trials. It has 7 active development programs and 4 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 3 registered with a 2026 start date. The dashed outline is the pace from the 3 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 4.8 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers UNIVERSITA' DEGLI STUDI DI GENOVA: 21 lead-sponsored trials and 1 legal-entity registration.
Disease areas (54)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Multiple Sclerosis | 6 |
| Aortic Dissection | 3 |
| Parkinson Disease | 3 |
| Alveolar Bone Loss | 2 |
| Bone Resorption | 2 |
Showing 5 of 54 disease areas.
Trials by start year as sponsor or collaborator (16)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 4 |
| 2024 | 5 |
| 2023 | 5 |
| 2022 | 7 |
| 2021 | 5 |
| 2020 | 1 |
| 2019 | 3 |
| 2018 | 3 |
| 2017 | 1 |
Showing 10 of 16 years.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (7)
Shown in this order: max phase, then active trials.
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| Fluid balance | Brain Injuries, Traumatic | Not reported | 1 |
| Fluid balance | Brain Injuries | Not reported | 1 |
| Fluid balance | Edema | Not reported | 1 |
| data collection | Renal Insufficiency, Chronic | Not reported | 1 |
| data collection | Acute Kidney Injury | Not reported | 1 |
Showing 5 of 7 active programs.
Approved assets (4)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| Amoxicillin Long | 1 |
| Amoxicillin Short | 1 |
| VEDOLIZUMAB | 1 |
| Cangrelor | 1 |
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 1 of 1 hit target (n=1) | 0 of 1 on time (n=1) |
Journals published in (113)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Journal of neurology | 8 |
| The New England journal of medicine | 5 |
| Critical care medicine | 4 |
| Intensive care medicine | 4 |
| Archives of physical medicine and rehabilitation | 3 |
Showing 5 of 113 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 38 | 7 | 2025-01-28 |
Organization relationships (46)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Istituti di Ricovero e Cura a Carattere Scientifico | Co sponsors trial with | 6 |
| Fondazione Italiana Sclerosi Multipla | Co sponsors trial with | 4 |
| University of Florence | Co sponsors trial with | 2 |
| Federico II University | Co sponsors trial with | 2 |
| University of Turin, Italy | Co sponsors trial with | 2 |
Showing 5 of 46 relationships.
Latest dated events (84)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-05 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-05-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-04-10 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-11-02 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-10-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 84 events.
Biomarker capability evidence (20)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| ATP12A | Trial collaborator | Named in trial inclusion criteria |
| ATP4A | Trial collaborator | Named in trial inclusion criteria |
| CCNG1 | Trial collaborator | Named in trial exclusion criteria |
| GGT1 | Trial collaborator | Named in trial exclusion criteria |
| MAG | Trial collaborator | Named in trial exclusion criteria |
Showing 5 of 20 evidence rows.
Biomarkers this organization publishes on (905)
Shown in this order: most publications first.
Showing 5 of 905 biomarkers.
On Scientist.com
UNIVERSITA' DEGLI STUDI DI GENOVA is listed as a research supplier in the Scientist.com network.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.
Work with University of Genoa (Universita Degli Studi Di Genova) on Scientist.com
For prices, more details, or to contact University of Genoa (Universita Degli Studi Di Genova), visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.